Tagged Articles

hrt-legal.com 49 articles

hormone replacement therapy

hormone replacement therapy (hrt) places women at a greater risk for breast cancer, blood clots, heart attack and stroke

Hormone Replacement Therapy (HRT) is medication containing one or more female hormones, commonly estrogen plus progestin. HRT is often prescribed to treat symptoms of menopause such as “hot flashes,” vaginal dryness, mood swings, sleep disorders, and decreased sexual desire. This medication may be taken in the form of a pill, a patch, or vaginal cream.

Until recently, doctors believed the long-term use of hormone replacement therapy drugs such as Premarin, Provera, and Prempro were safe and protected against osteoporosis and heart disease.

However, recent studies now show that hormone replacement therapy places women at a higher risk for:

breast cancer
ovarian cancer
non-hodgkins lymphoma
heart attack
blood clots
For more information, read the specific criteria for qualified HRT injuries.

have you been seriously injured while on hrt?

If you or a loved one has suffered serious side effects while taking HRT drugs such as Premarin, Provera, and Prempro, if you have been diagnosed with breast cancer, or if you experiencing symptoms associated with breast cancer, you may have a claim against the manufacturer.

Please contact us today by filling out the brief questionnaire, or by calling our toll free number (1-800-898-2034) for a free, no-cost no-obligation evaluation of your case.

Compensatory and punitive damages awarded in HRT lawsuit

Hundreds of lawsuits alleging that Wyeth Pharmaceuticals’ hormone replacement therapies (HRT) caused breast cancer have been settled in recent months including one in Pennsylvania where a judge upheld a verdict against the drug company, including a $6 million punitive damages award. Wyeth had heavily promoted its HRT drugs Premarin and Prempro as safe and effective treatments for bothersome symptoms of menopause. The pharmaceutical company even promoted the pills for their added benefit of protecting women against heart disease and dementia. But evidence was beginning to surface that the drugs were actually far more dangerous than the public or doctors ever ... Read More

Study finds HRT breast cancers are more likely to be advanced, deadly

The evidence weighing the benefits and risks of hormone replacement therapy (HRT) in menopausal and postmenopausal women continues to tip toward the same conclusion – that taking HRT is dangerous. HRT was once heralded as a cure-all for problematic symptoms of menopause, including hot flashes, sleeping difficulties, mood swings and vaginal dryness. It was also given the added benefit of protecting women against heart disease and osteoporosis. However, opinion quickly changed in 2002, after a large study of postmenopausal women found that HRT that combined the hormones estrogen and progesterone increased a woman’s risk for breast cancer by about one extra ... Read More

Herbal alternative to HRT denied FDA approval

An herbal remedy for menopause symptoms marketed in Japan failed to show benefits among American women, according to a recent study published in the journal Menopause. The pill, known as TU-025, combines cinnamon bark, peach pits and several other botanicals, and is regulated as a prescription drug in Japan. It is commonly used by Japanese gynecologists to treat hot flashes in menopausal women. The drug’s maker, Tokyo-based Tsumura & Company, helped fund a study to see if the benefits would also be seen in American women. The consensus was that if it proved beneficial, the herb could offer a safer ... Read More

Drop in breast cancer rates coincides with drop in HRT use

A drop in breast cancer rates in Canada in the past 10 years goes hand-in-hand with a decrease in the use of hormone replacement therapy (HRT), according to a new study.For the study, researchers analyzed national data and found a near-10 percent drop in invasive breast cancer rates among Canadian women aged 50 to 69, which researchers say coincides with the decline of HRT use among women. The largest drop in HRT use occurred between 2002 and 2004, when usage fell from 12.7 percent to 4.9 percent. During the same years, breast cancer rates dropped nearly 10 percent. Breast cancer ... Read More

Breast cancer risk outweighs HRT PAD benefit

A new study suggests that hormone replacement therapy (HRT) may decrease the prevalence of peripheral arterial disease (PAD), even in women who had known risk factors such as smoking, hypertension, and high cholesterol. However, researchers are not suggesting women use HRT to prevent the condition as the drug has also been linked to cancer, strokes and other cardiovascular risks. PAD, which is also referred to peripheral vascular disease, is a condition of the blood vessels that leads to narrowing and hardening of the arteries that supply the legs and feet. People with PAD have an exceptionally elevated risk for cardiovascular ... Read More

Dr. Oz warns post-menopausal guest to stay away from HRT

How important is it for a post-menopausal woman to take hormone replacement therapy (HRT)? Audience member Rosemarie posed the question to Dr. Oz, the popular television doctor. Rosemarie says she became post-menopausal three years ago and she has never taken HRT. Hormone replacement therapy was designed to boost hormone levels in menopausal and post-menopausal women and help them deal with symptoms such as irritability, night sweats, hot flashes, vaginal dryness and sleeplessness. If you asked drug companies – especially 20 years ago when HRT was widely prescribed – they would rattle off a laundry list of extra benefits ranging from ... Read More

New study can leave women even more confused about HRT

New research on hormone replacement therapy (HRT) and birth control pills could leave women even more confused about the risks and benefits of the drugs, doctors warn. The research, published in the Journal of NeuroInterventional Surgery, suggests that pills containing estrogen may help lower the risk for brain aneurysms. The news follows a tidal wave of studies that linked HRT to breast cancer and other deadly conditions including ovarian cancer, non-Hodgkin’s lymphoma, heart attack, stroke and blood clots. “I think women are confused,” Dr. Joanna Longstaffe, clinical director of Independent General Practice told Wales Online. “I have far fewer people ... Read More

Depo-Provera’s new label warns of breast cancer, bone density loss

Depo-Provera (medroxyprogesterone acetate), the injectable contraceptive, has updated its safety label to include warnings of breast cancer risk and bone mineral density loss. The new label changes were approved by the Food and Drug Administration (FDA) and will go into effect immediately. Depo-Provera is an injection used to prevent pregnancy. It is also used to treat endometriosis. The drug is in a class of medications called progestins that work to prevent pregnancy by preventing ovulation and thinning the lining of the uterus. It is administered through injection into the upper arm or buttocks, and is usually given once every three ... Read More

New study finds HRT increases women’s risk for kidney stones

Hormone replacement therapy (HRT) is blamed for increasing a woman’s risk of breast and ovarian cancer, heart attacks and strokes. Now, a new research study shows the pills also increase women’s risk of developing painful kidney stones. The landmark government research studied 24,000 postmenopausal women taking either HRT or placebo, and found that women on HRT were 21 percent more likely to develop kidney stones over a five-year period. The risks were equal among women taking Prempro, pills containing estrogen plus progestin, and Premarin, estrogen-only pills. Comparatively, studies show that overall about 6 percent of postmenopausal women develop kidney stones. ... Read More

Study: HRT puts women at greater risk for lung cancer

The reports of health problems associated with hormone replacement therapy (HRT) keep coming. First, the Women’s Health Initiative identified women who took the combined estrogen-plus-progestin therapy were at a much greater risk of developing breast cancer. It later showed these women were at an increased risk of heart disease and other serious health problems. Now, an article published online in the Journal of Clinical Oncology suggests that women who took combined HRT are at an increased risk of lung cancer by as much as 50 percent. The level of risk seemed to increase with the duration of therapy. Women who took ... Read More